Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Apr 15;9(4):1956-1959.
eCollection 2017.

Erythema elevatum diutinum involving palms and soles: a case report and literature review

Affiliations
Case Reports

Erythema elevatum diutinum involving palms and soles: a case report and literature review

Uma Keyal et al. Am J Transl Res. .

Abstract

Erythema elevatum diutinum (EED) is a rare chronic inflammatory dermatosis and a part of the spectrum of cutaneous leukocytoclasticvasculitis. The most common site of involvement is extensor surface of the extremities, with a predilection for the skin overlying joints, particularly hands, feet, elbows and knees, as well as buttocks and Achilles tendons. Here we report a case of EED with atypical presentation involving palms and soles. The patient showed dramatic response to the treatment with prednisolone combined with Tripterygium wilfordii glycoside (TWP). The lesions improved significantly after three months of therapy. We will also review the atypical cases of EED that were previously published in English literature.

Keywords: Erythema elevatum diutinum; leukocytoclasticvasculitis; multiple myeloma.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Clinical picture of patient before and after treatment. A: Voilaceous nodule on erythematous base on left lateral foot; B: Reddish papular lesions with scales involving multiple toes; C: Dry scaly plaque with multiple hemorrhagic spots of different size on right foot; D: Papulonodular lesion on palms. Some papules have coalesced to form plaque; E: 3 months after treatment lesion disappeared leaving slight hyperpigmentation; F: 3 months after treatment the lesion improved; G: 3 months after treatment decrease in the thickness of plaques and nodules.
Figure 2
Figure 2
Histopathology. A: Histology shows diffuse neutrophil infiltration and fibroplasia in the dermis (Hematoxylin and eosin stain; original magnification ×4); B: Histology shows broken neutrophils and scanty eosinophils in the dermis (Hematoxylin and eosin stain; original magnification ×40).

References

    1. Gibson LE, el-Azhary RA. Erythema elevatum diutinum. Clin Dermatol. 2000;18:295–299. - PubMed
    1. Cirvidiu DC, Elias BL, Jorge JC, Lira ML, Mandelbaum SH. Erythema elevatum diutinum and hypothyroidism: coincidence or causal relationship? An Bras Dermatol. 2015;90:561–563. - PMC - PubMed
    1. Wilkinson SM, English JS, Smith NP, Wilson-Jones E, Winkelmann RK. Erythema elevatum diutinum: a clinicopathological study. Clin Exp Dermatol. 1992;17:87–93. - PubMed
    1. Futei Y, Konohana I. A case of erythema elevatum diutinum associated with B-cell lymphoma: a rare distribution involving palms, soles and nails. Br J Dermatol. 2000;142:116–119. - PubMed
    1. Ma L, Liu B, Jiang Z, Jiang Y. Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Rheumatol. 2014;33:187–195. - PubMed

Publication types

LinkOut - more resources